Please login to the form below

academia

This page shows the latest academia news and features for those working in and with pharma, biotech and healthcare.

Novartis and Sanofi heads take on UK pharma leadership roles

world. “In the current Brexit environment, it is more important than ever to collaborate across government, businesses and academia to ensure that the UK can maintain its position as a leader

Latest news

UCB looks to pipeline with five years left for twin blockbusters

drug discovery partnership with King’s College London university and its research teams working across academia and the NHS.
Merck & Co to buy IO specialists Immune Design for $300m

Big pharma, biotech and academia are zeroing in on a range of immune system mechanisms which could prove crucial to fighting diverse diseases.
UCB signs research deal with King’s College London

our world class expertise in translational research and clinical development at King’s with UCB’s long and successful track record of partnering with UK academia will yield successful benefits for
A genomics and digital-led NHS is possible – but investment in staff essential

It is logical that progress in meeting these challenges will be most effectively addressed through collaboration across industry, NHS and academia.
Skills shortage and Brexit will hit R&D, warns UK pharma

UK science and academia are the envy of the world and the we are vying to be Europe’s premier biotech cluster and second only to the US. But we are

More from news
Approximately 7 fully matching, plus 134 partially matching documents found.

Latest Intelligence

Biotech profile: Tom Evans, CEO, Vaccitech.

Tom Evans. Pharma Market Europe talks to its chief executive Tom Evans, a veteran research and business leader in viral diseases, with experience across academia, big pharma and biotech.
The social dilemma: is it time for pharma to join the party?

Pharma’s reliance on KOLs is a worthwhile bridge to academia, but does it connect them to the ‘shop-floor’ clinicians or the diverse community of medical professionals who engage patients
25 Women Leaders in UK Healthcare

academia, and digital health.
Brain power: fresh approaches to Alzheimer’s drug discovery

The failure to make progress against Alzheimer’s disease over the last 20 years has forced governments, academia and the pharma industry to think outside the box. ... Sir Simon Lovestone. After 18 years in old age psychiatry and dementia research in
Nudge-nudge, think-think

As such, companies should develop programmes that combine the valuable insights from science and reality, basing interventions on the latest studies in academia that have been tailored to meet specific needs ... Moreover, as the science evolves, academia

More from intelligence
Approximately 1 fully matching, plus 33 partially matching documents found.

Latest appointments

New hires at Nanoform, Leo Pharma and Calliditas

Sandler comes to Nanoform with extensive experience in both industry and academia, particularly in pharmaceutical product development and material science.
Kevin Sin joins GSK

Gaining access to the best science and technologies across the world as well as establishing highly productive collaborations with academia and industry, play an important role in creating a world-class
Professor Carole Longson moves from NICE to the ABPI

experience, expertise and network in both industry and academia will enable the ABPI to work with our partners to further these objectives.”.
Orion appoints VP of oncology, R&D

I hope that my long background in the academia will help in the initiation of new research projects between Orion and the academia.
Storm Therapeutics strengthens its board

I look forward to working with the board to help guide Storm’s innovative research programmes, adding my experience from drug discovery in academia, pharma and biotech.”.

More from appointments
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest from PMHub

Cello Health launches ‘Cello Health GmbH’ with new Berlin office and appointment of two regional directors to lead the Business Insights and Analytics division in Germany.

companies as well as associated industries and academia.
Porterhouse Medical Group strengthens its US scientific team

His excellent heritage from academia, through agency, then pharma and back to the consulting and agency world – means that he has an excellent appreciation of client needs and how best an
The problem with the ‘recovery’ conversation in mental health

The narrative widely told in both the media and in academia typically describes an individual who has ‘recovered’ from a one-off episode of depression at some point in the past.
Random42 Partner with MedCity for BioJapan 2018

Random42 have partnered with MedCity to attend the event as part of the UK delegation, which aims to showcase the UK’s ecosystem and forge collaborations with Japanese pharma and academia. ... We facilitate connectivity across industry, academia
Pegasus opens health track at Cannes Lions

Hehir, showing that the seemingly very different worlds of creative agencies and academia can come together to embed behaviour change theory into the creative process.